Pacira BioSciences, Inc.Pacira BioSciences, Inc.Pacira BioSciences, Inc.

Pacira BioSciences, Inc.

No trades
See on Supercharts

Price target

18.750.000.00%
The 8 analysts offering 1 year price forecasts for PCRX have a max estimate of — and a min estimate of —.

Analyst rating

Based on 9 analysts giving stock ratings to PCRX in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


PCRX EPS for the last quarter is 0.79 USD despite the estimation of 0.70 USD. In the next quarter EPS is expected to reach 0.78 USD. Track more of Pacira BioSciences, Inc. financials and stay on top of what is up with the company.
In the next quarter Pacira BioSciences, Inc. revenue is expected to reach ‪179.20 M‬ USD. Check out Pacira BioSciences, Inc. revenue and earnings and make informed decisions.
According to analysts, PCRX price target is 18.75 USD with a max estimate of 39.00 USD and a min estimate of 8.00 USD. Check if this forecast comes true in a year, meanwhile watch Pacira BioSciences, Inc. stock price chart and keep track of the current situation with PCRX news and stock market news.
We've gathered opinions of 9 analysts rating PCRX stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.